Skip to main content
. 2015 Sep 10;6(32):33972–33981. doi: 10.18632/oncotarget.5583

Figure 3. Survival analysis according PD-L1 expression(A, DFS; B, DMFS; C, cancer-specific OS; D, OS).

Figure 3